BG-12 (dimethyl fumarate) is in development as an oral treatment for relapsing–remitting multiple sclerosis, which is commonly treated with parenteral agents (interferon or glatiramer acetate). In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback